John Lee
Obstetrics & Gynecology · Milton, FLNPI 1245276088
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 666 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,574 and has fallen 75.1% since, to $641 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 666 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$990
- Novo Nordisk$759
- Almatica Pharma LLC$754
- Axsome Therapeutics, Inc.$611
- Amgen$509
- plus $6K from 54 others
What the payments were for
- Food & beverage$10,89297%
- Education$3323%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,224 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 151 | $159,871 |
| MounjaroTirzepatide | 72 | $79,819 |
| XyostedTestosterone Enanthate | 66 | $40,861 |
| LinzessLinaclotide | 35 | $32,358 |
| FarxigaDapagliflozin Propanediol | 29 | $31,581 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 24 | $24,378 |
| EliquisApixaban | 28 | $19,232 |
| TrulicityDulaglutide | 14 | $19,025 |
| VascepaIcosapent Ethyl | 25 | $18,500 |
| DuaveeEstrogens,conj/Bazedoxifene | 64 | $16,635 |
| JardianceEmpagliflozin | 14 | $16,125 |
| VyvanseLisdexamfetamine Dimesylate | 40 | $15,831 |
| MyrbetriqMirabegron | 19 | $15,149 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $14,135 |
| JanuviaSitagliptin Phosphate | 13 | $12,362 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $759 | $159,871151 claims |
| Lilly USA, LLCMounjaro, Trulicity | $331 | $98,84386 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $990 | $62,51770 claims |
| PfizerEliquis, Duavee, Premarin | $236 | $43,546117 claims |
| Antares Pharma, Inc.Xyosted | $202 | $40,86166 claims |
| AbbVieLinzess, Synthroid | $1,261 | $40,180112 claims |
| MerckJanuvia, Janumet Xr | $183 | $18,51424 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $201 | $15,83140 claims |
| Astellas Pharma US IncMyrbetriq | $388 | $15,14919 claims |
| GSKTrelegy Ellipta | $381 | $14,13515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Other obstetrics & gynecology in Milton
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Keith AquaWellington$473K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.